Drug: Bevacizumab Injury: Hypophosphataemia Quarter: 2016Q3
Total Records: 28 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127451141 | Bevacizumab | Hypophosphataemia | ROCHE | 60.00 YR | F | 0 | 20160915 | US |
127555931 | Bevacizumab | Hypophosphataemia | ROCHE | 61.00 YR | F | 61 KG | 20160916 | US |
127580821 | Bevacizumab | Hypophosphataemia | ROCHE | 40.00 YR | M | 0 | 20160919 | US |
127873111 | Bevacizumab | Hypophosphataemia | ROCHE | 63.00 YR | F | 99 KG | 20160927 | US |
127905841 | Bevacizumab | Hypophosphataemia | ROCHE | 56.00 YR | F | 69 KG | 20160929 | US |
127911311 | Bevacizumab | Hypophosphataemia | ROCHE | 0.00 | F | 63 KG | 20160929 | US |
127911541 | Bevacizumab | Hypophosphataemia | ROCHE | 63.00 YR | F | 69 KG | 20160929 | US |
127975691 | Bevacizumab | Hypophosphataemia | ROCHE | 75.04 YR | F | 71 KG | 20160930 | US |
Total Records: 28 Number of Pages: 2